Mineralys Therapeutics, Inc. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

Mineralys Therapeutics, Inc. (MLYS) — Frequently Asked Questions

Mineralys Therapeutics, Inc. (MLYS) is a publicly traded US company. Explore MLYS's stock price, financial statements, earnings history, margins and key ratios below.

What is the MLYS stock price?

MLYS trades at $23.76 (-1.74% on the day).